Canadian Imperial Bank of Commerce (LON:0UNI)
120.29
+0.18 (0.15%)
At close: Nov 27, 2025
LON:0UNI Revenue
Canadian Imperial Bank of Commerce had revenue of 4.83B CAD in the quarter ending July 31, 2025, with 8.99% growth. This brings the company's revenue in the last twelve months to 18.55B, up 12.05% year-over-year. In the fiscal year ending October 31, 2024, Canadian Imperial Bank of Commerce had annual revenue of 16.94B with 10.26% growth.
Revenue (ttm)
18.55B CAD
Revenue Growth
+12.05%
P/S Ratio
4.22
Revenue / Employee
382.19K CAD
Employees
48,525
Market Cap
59.95B GBP
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 16.94B | 1.58B | 10.26% |
| Oct 31, 2023 | 15.36B | 104.18M | 0.68% |
| Oct 31, 2022 | 15.26B | -774.85M | -4.83% |
| Oct 31, 2021 | 16.04B | 3.84B | 31.50% |
| Oct 31, 2020 | 12.19B | -961.79M | -7.31% |
| Oct 31, 2019 | 13.16B | 264.35M | 2.05% |
| Oct 31, 2018 | 12.89B | 906.87M | 7.57% |
| Oct 31, 2017 | 11.99B | 1.56B | 15.00% |
| Oct 31, 2016 | 10.42B | 428.36M | 4.29% |
| Oct 31, 2015 | 9.99B | -1.05B | -9.53% |
| Oct 31, 2014 | 11.05B | -45.79M | -0.41% |
| Oct 31, 2013 | 11.09B | -101.22M | -0.90% |
| Oct 31, 2012 | 11.19B | -147.93M | -1.30% |
| Oct 31, 2011 | 11.34B | 522.49M | 4.83% |
| Oct 31, 2010 | 10.82B | 3.14B | 40.97% |
| Oct 31, 2009 | 7.67B | 5.26B | 217.33% |
| Oct 31, 2008 | 2.42B | -9.66B | -79.97% |
| Oct 31, 2007 | 12.08B | 2.47B | 25.72% |
| Oct 31, 2006 | 9.61B | -389.23M | -3.89% |
| Oct 31, 2005 | 9.99B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |